title: [Severe asthma--where are we today?].
abstract: Severe asthma is defined by persistent symptoms and frequent exacerbations despite intensive asthma therapy. The prevalence is estimated to be 5-10% of all asthmatics. Severe asthma is responsible for a major burden of illness including low quality of life and a disproportionate use of health-care resources. The clinical assessment of severe asthma must include verification of the correct diagnosis, adherence to medication, excluding differential diagnosis and identification and treatment of aggravating co-morbidities and trigger factors.
authors.affiliation: Lungemedicinsk Forskningsenhed, Bispebjerg Hospital, Bispebjerg Bakke 23, 2400 København NV. annavonbulow@gmail.com.
authors.forename: Anna
authors.initials: A
authors.lastname: von Bülow
authors.forename: Vibeke
authors.initials: V
authors.lastname: Backer
authors.forename: Celeste
authors.initials: C
authors.lastname: Porsbjerg
mesh_terms: D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001249:Asthma / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy; D015897:Comorbidity; D003937:Diagnosis, Differential; D006801:Humans; D055118:Medication Adherence; D012720:Severity of Illness Index
chemical_list: D018927:Anti-Asthmatic Agents